🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Clonmel Healthcare Ltd — Licensed Medicines

427 medicines held by Clonmel Healthcare Ltd on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 427 products held by Clonmel Healthcare Ltd
MedicineActive substanceLicence holderStatus
Olmesartan Medoxomil Clonmel 20 mg film-coated tablets
PA0126/273/002
 Olmesartan medoxomil Clonmel Healthcare Ltd Marketed
Olmesartan Medoxomil Clonmel 40 mg film-coated tablet
PA0126/273/003
 Olmesartan medoxomil Clonmel Healthcare Ltd Marketed
Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Clonmel 20 mg/5 mg/12.5 mg film-coated tablets
PA0126/312/001
 Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Clonmel 40 mg/10 mg/12.5 mg film-coated tablets
PA0126/312/003
 Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Clonmel 40 mg/10 mg/25 mg film-coated tablets
PA0126/312/005
 Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Clonmel 40 mg/5 mg/12.5 mg film-coated tablets
PA0126/312/002
 Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Clonmel 40 mg/5 mg/25 mg film-coated tablets
PA0126/312/004
 Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Olmesartan/Amlodipine Clonmel 20 mg/5 mg film-coated tablets
PA0126/293/001
 Olmesartan medoxomil, Amlodipine besilate Clonmel Healthcare Ltd Marketed
Olmesartan/Amlodipine Clonmel 40 mg/10 mg film-coated tablets
PA0126/293/003
 Olmesartan medoxomil, Amlodipine besilate Clonmel Healthcare Ltd Marketed
Olmesartan/Amlodipine Clonmel 40 mg/5 mg film-coated tablets
PA0126/293/002
 Olmesartan medoxomil, Amlodipine besilate Clonmel Healthcare Ltd Marketed
Olmesartan/Hydrochlorothiazide Clonmel 20 mg/12.5 mg film-coated tablets
PA0126/260/001
 Olmesartan medoxomil, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Olmesartan/Hydrochlorothiazide Clonmel 20 mg/25 mg film-coated tablets
PA0126/260/002
 Olmesartan medoxomil, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Olmesartan/Hydrochlorothiazide Clonmel 40 mg/12.5 mg film-coated tablets
PA0126/260/003
 Olmesartan medoxomil, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Olmesartan/Hydrochlorothiazide Clonmel 40 mg/25 mg film-coated tablets
PA0126/260/004
 Olmesartan medoxomil, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Opticrom 2 % w/v Eye Drops, solution
PA0126/381/001
 Sodium cromoglicate Clonmel Healthcare Ltd Not marketed
Opticrom allergy 2% w/v eye drops, solution
PA0126/381/002
 Sodium cromoglicate Clonmel Healthcare Ltd Marketed
Opticrom Allergy Single Dose 2% w/v eye drops, solution
PA0126/381/003
 Sodium cromoglicate Clonmel Healthcare Ltd Marketed
Osteomel Once Weekly 70 mg tablets
PA0126/148/002
 Alendronic acid Clonmel Healthcare Ltd Marketed
Paliperidone Clonmel 100 mg prolonged-release suspension for injection in pre-filled syringe
PA0126/370/003
 Paliperidone palmitate Clonmel Healthcare Ltd Not marketed
Paliperidone Clonmel 150 mg prolonged-release suspension for injection in pre-filled syringe
PA0126/370/004
 Paliperidone palmitate Clonmel Healthcare Ltd Not marketed
Paliperidone Clonmel 50 mg prolonged-release suspension for injection in pre-filled syringe
PA0126/370/001
 Paliperidone palmitate Clonmel Healthcare Ltd Not marketed
Paliperidone Clonmel 75 mg prolonged-release suspension for injection in pre-filled syringe
PA0126/370/002
 Paliperidone palmitate Clonmel Healthcare Ltd Not marketed
Pantium 20 mg gastro-resistant tablets
PA0126/175/001
 Pantoprazole sodium sesquihydrate Clonmel Healthcare Ltd Marketed
Pantium 40mg Gastro-Resistant Tablets
PA0126/175/002
 Pantoprazole sodium sesquihydrate Clonmel Healthcare Ltd Marketed
Paralief 500 mg Effervescent Tablets
PA0126/020/004
 Paracetamol Clonmel Healthcare Ltd Marketed
Paralief 500 mg film-coated tablets
PA0126/020/008
 Paracetamol Clonmel Healthcare Ltd Marketed
Paralief 500 mg soft capsules
PA0126/020/007
 Paracetamol Clonmel Healthcare Ltd Marketed
Paralief 500mg Tablets
PA0126/020/001
 Paracetamol Clonmel Healthcare Ltd Not marketed
Paralief Cold & Flu hard capsules Paracetamol 300 mg Caffeine 25 mg Phenylephrine hydrochloride 5 mg
PA0126/272/001
 Paracetamol, Caffeine, Phenylephrine hydrochloride Clonmel Healthcare Ltd Not marketed
Paralief Hot Lemon Drink 600 mg powder for oral solution in sachet
PA0126/020/006
 Paracetamol Clonmel Healthcare Ltd Marketed
Paralief Max 1000 mg Effervescent Tablets
PA0126/020/005
 Paracetamol Clonmel Healthcare Ltd Not marketed
Pemetrexed Clonmel 25 mg/ml concentrate for solution for infusion
PA0126/270/001
 Pemetrexed Disodium 2.5 hydrate Clonmel Healthcare Ltd Marketed
Perdamel 0.5 mg film-coated tablets
PA0126/169/002
 Risperidone Clonmel Healthcare Ltd Marketed
Perdamel 1 mg film-coated tablets
PA0126/169/003
 Risperidone Clonmel Healthcare Ltd Marketed
Perdamel 2 mg film-coated tablets
PA0126/169/004
 Risperidone Clonmel Healthcare Ltd Marketed
Perdamel 3 mg film-coated tablets
PA0126/169/005
 Risperidone Clonmel Healthcare Ltd Marketed
Perdamel 4 mg film-coated tablets
PA0126/169/006
 Risperidone Clonmel Healthcare Ltd Marketed
Perindopril Arginine Clonmel 10 mg film-coated tablets
PA0126/366/002
 Perindopril arginine Clonmel Healthcare Ltd Marketed
Perindopril Arginine Clonmel 2.5 mg film-coated tablets
PA0126/366/003
 Perindopril arginine Clonmel Healthcare Ltd Not marketed
Perindopril Arginine Clonmel 5 mg film-coated tablets
PA0126/366/001
 Perindopril arginine Clonmel Healthcare Ltd Not marketed
Phenobarbital 15 mg Tablets
PA0126/019/001
 Phenobarbital Clonmel Healthcare Ltd Marketed
Phenobarbital 30 mg Tablets
PA0126/019/002
 Phenobarbital Clonmel Healthcare Ltd Marketed
Piperacillin/Tazobactam Clonmel 4 g/0.5 g powder for solution for infusion
PA0126/363/001
 Tazobactam, Piperacillin Clonmel Healthcare Ltd Not marketed
Pipercin 4 g/0.5 g powder for solution for infusion
PA0126/180/002
 Piperacillin, Tazobactam Clonmel Healthcare Ltd Marketed
Pirfenidone Clonmel 267 mg film-coated tablets
PA0126/350/001
 Pirfenidone Clonmel Healthcare Ltd Marketed
Pirfenidone Clonmel 801 mg film-coated tablets
PA0126/350/002
 Pirfenidone Clonmel Healthcare Ltd Marketed
Pomalidomide Clonmel 1 mg hard capsules
PA0126/378/001
 Pomalidomide Clonmel Healthcare Ltd Marketed
Pomalidomide Clonmel 2 mg hard capsules
PA0126/378/002
 Pomalidomide Clonmel Healthcare Ltd Marketed
Pomalidomide Clonmel 3 mg hard capsules
PA0126/378/003
 Pomalidomide Clonmel Healthcare Ltd Marketed
Pomalidomide Clonmel 4 mg hard capsules
PA0126/378/004
 Pomalidomide Clonmel Healthcare Ltd Marketed
← 3 4 5 6 7 8 9 →

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.